393
Participants
Start Date
February 13, 2020
Primary Completion Date
July 29, 2022
Study Completion Date
June 30, 2026
Lazertinib 240 mg/160 mg
The initial dose of lazertinib 240 mg (3 tablets of 80 mg lazertinib) once daily can be reduced to 160 mg once daily (2 tablets of 80 mg lazertinib) under specific circumstances
Gefitinib 250 mg
The initial dose for Gefitinib (250 mg once daily) cannot be reduced to a lower dose
Lazertinib-matching placebo 240 mg/160 mg
The initial dose of lazertinib-matching placebo 240 mg (3 tablets of 80 mg lazertinib-matching placebo) once daily can be reduced to 160 mg once daily (2 tablets of 80 mg lazertinib-matching placebo) under specific circumstances
Gefitinib-matching placebo 250 mg
The initial dose for Gefitinib-matching placebo (250 mg once daily) cannot be reduced to a lower dose
Manila Doctors Hospital - Clinical Trial Office, Manila
Philippine General Hospital, Manila
Adana Baskent Practice and Research Hospital, Adana
Cukurova University Medical Faculty, Adana
Törökbálinti Tüdőgyógyintézet, Törökbálint
Kyiv City Clinical Oncology Center - Department of Chemotherapy, Kyiv
Princess Alexandra Hospital, Woolloongabba
Perpetual Succour Hospital, Cebu
Hacettepe University Medical Faculty - Medical Oncology, Ankara
National Taiwan University Hospital, Taipei
Ramathibodi Hospital, Mahidol University, Bangkok
Hospital Pulau Pinang, George Town
National Cancer Center, Goyang-si
Hospital Umum Sarawak, Kuching
Siriraj Hospital, Bangkok
"Clinical Hospital Center Bezanijska Kosa", Belgrade
Taipei Veterans General Hospital, Taipei
Eugenideio Therapeutirio - Ongcology Department, Athens
Attikon Hospital, Athens
CHA Bundang Medical Center, CHA University, Seongnam-si
Seoul National University Bundang Hospital, Seongnam-si
The Catholic University of Korea, Bucheon St. Mary's Hospital, Bucheon-si
Hospital Raja Perempuan Zainab Ii, Kota Bharu
The Catholic University of Korea, St. Vincent's Hospital, Suwon
Ajou University Hospital, Suwon
Podilskyi rehionalnyi tsentr onkolohii, viddilennia khimioterapii, Vinnytsia
Institute for Pulmonary Diseases of Vojvodina, Kamenitz
Gachon University Gil Medical Center, Incheon
Trakya University Medical Faculty, Edirne
Hospital Tengku Ampuan Afzan, Kuantan
Chungbuk National University Hospital, Cheongju-si
Clinical Center Kragujevac, Kragujevac
Istanbul Medeniyet University Goztepe Training and Research Hospital - Medical Oncology, Istanbul
Medical Point İzmir Hospital, Izmir
Srinagarind Hospital, Khon Kaen University, Khon Kaen
"Komunalne nekomertsiine pidpryiemstvo Sumskoi oblasnoi rady Sumskyi klinichnyi onkolohichnyi tsentr, onkotorakalne viddilennia, Sumskyi derzhavnyi universytet, kafedra onkolohii ta radiolohii, m. Sumy", Sumy
Kocaeli University Medical Faculty, Kocaeli
Yeungnam University Medical Center, Daegu
Keimyung University Dongsan Medical Center, Daegu
Ulsan University Hospital, Ulsan
Inonu University Turgut Ozal Medical Center, Malatya
Inje University Haeundae Paik Hospital, Busan
"Komunalne nekomertsiine pidpryiemstvo Miska klinichna likarnia №4 Dniprovskoi miskoi rady, khimioterapevtychne viddilennia z dennym statsionarom, Derzhavnyi zaklad Dnipropetrovskyi derzhavnyi medychnyi universitet, kafedra onkolohii i medychnoi radio", Dnipro
Chiang Mai University - Faculty of Medicine, Chiang Mai
Gyeongsang National University Hospital, Jinju
Theageneio Anticancer Hospital of Thessaloniki, Thessaloniki
"Oblasne komunalne nekomertsiine pidpryiemstvo Bukovynskyi klinichnyi onkolohichnyi tsentr, strukturnyi pidrozdil klinichnoi onkolohii, m.Chernivtsi", Chernivtsi
University Malaya Medical Centre, Kuala Lumpur
"Komunalne nekomertsiine pidpryiemstvo Kharkivskoi oblasnoi rady Oblasnyi klinichnyi spetsializovanyi dyspanser radiatsiinoho zakhystu naselennia - khirurhichne viddilennia", Kharkiv
"Medychnyi tsentr Tovarystva z obmezhenoiu vidpovidalnistiu Onkolaif", Zaporizhzhia
Hospital Sultan Ismail, Johor Bahru
Tsentralna miska klinichna likarnia, Uzhhorod
Prince of Songkla University, Hat Yai
Medincentre (GLAVUPDK), Moscow
National University Hospital, Singapore
VitaMed LLC, Moscow
Yaroslavl regional oncology hospital, Yaroslavl
Arkhangelsk Regional Clinical Oncological Dispensary, Arkhangelsk
"Private medical institution Euromedservice", Pushkin
First St. Petersburg State Medical University n. a. Pavlov, Saint Petersburg
"LLC Eurocityclinic", Saint Petersburg
"Limited Liability Company AV Medical Group - Oncology", Saint Petersburg
Saint-Petersburg City Clinical Oncology Dispensary, Saint Petersburg
"GBUZ Regional clinical oncologic dispensary of Volgograd", Volgograd
GAUZ Republican clinical oncology dispensary of the Ministry, Kazan'
Republic Clinical Oncology Despensary, Kazan'
GBUZ of Nizhny Novgorod region Clinical diagnostic center, Nizhny Novgorod
"Budgetary Healthcare Institution of Omsk Region Clinical Oncology Dispensary", Omsk
Korea University Anam Hospital, Seoul
Seoul National University Hospital, Seoul
Kangbuk Samsung Hospital, Seoul
The Catholic University of Korea, Eunpyeong St.Mary's Hospital, Seoul
Severance Hospital, Seoul
Asan Medical Center, Seoul
Samsung Medical Center, Seoul
The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul
SMG-SNU Boramae Medical Center, Seoul
Ankara Liv Hospital, Ankara
Debreceni Egyetem, Debrecen
MBUZ City Clinical Hospital #1, Novosibirsk
Yuhan Corporation
INDUSTRY